| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $240K | -80.2% | -89.9% |
| R&D Expense | $151.5M | +55.3% | -22.4% |
| SG&A Expense | $22.2M | -0.2% | -13.6% |
| Operating Income | -$173.4M | -46.5% | +25.0% |
| Pre-tax Income | -$163.0M | -47.1% | +23.7% |
| Income Tax | $168K | -1.2% | -5.1% |
| Net Income | -$163.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $170.1M | -19.4% | +1.0% |
| Short-term Investments | $327.8M | -15.5% | -55.7% |
| Current Assets | $545.7M | -25.8% | -47.9% |
| Total Assets | $1.02B | -14.5% | -32.0% |
| Current Liabilities | $75.2M | -28.4% | -35.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$365.9M | — | — |
| Capital Expenditures | $4.5M | — | — |
| Investing Cash Flow | $223.7M | — | — |
| Financing Cash Flow | $2.7M | — | — |
| Free Cash Flow | -$370.4M | — | — |
| -47.0% |
| +23.7% |
| EPS (Basic) | -$1.17 | -46.2% | +25.0% |
| EPS (Diluted) | -$1.17 | -46.2% | +25.0% |
| $223.4M |
| -8.9% |
| -13.3% |
| Stockholders' Equity | $796.1M | -16.0% | -35.8% |